This section is not available in the published analysis.
XDEMVY® (lotilaner ophthalmic solution) 0.25%: Audience
XDEMVY® is the first and only FDA-approved treatment specifically designed for Demodex blepharitis, a prevalent eyelid disease. It aims to provide relief for millions of patients suffering from this condition.